Advanz Limits Takeda Patent Team's Access To Biosimilar Info
A London judge restricted the activities of two in-house lawyers at Takeda on Friday to ensure they don't use Advanz's confidential information for purposes that fall outside their ongoing bowel disease...To view the full article, register now.
Already a subscriber? Click here to view full article